Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder（MAAP-NMO），A Prospective, Multicenter Cohort Study

NCT07182409 is registered in ClinicalTrials.gov with First Affiliated Hospital of Chongqing Medical University as lead sponsor.

NCT NCT07182409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder（MAAP-NMO），A Prospective, Multicenter Cohort Study
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
June 30, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nmosd